| P2093 | author name string | K M Standifer | |
| P2860 | cites work | Phenocopy of discoidin I-minus mutants by antisense transformation in Dictyostelium | Q52264434 |
| | Antisense knockouts: molecular scalpels for the dissection of signal transduction | Q57204061 |
| | Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-labeled antisense oligodeoxynucleotides in the rat | Q71917187 |
| | Synergistic brainstem interactions for morphine analgesia | Q72636203 |
| | Antisense ablation of type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission | Q77581275 |
| | RGS3 inhibits G protein-mediated signaling via translocation to the membrane and binding to Galpha11 | Q22008566 |
| | Diversity of G proteins in signal transduction | Q29618841 |
| | Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents | Q34540878 |
| | Antisense Oligodeoxynucleotides to the Cloned δ Receptor DOR‐1: Uptake, Stability, and Regulation of Gene Expression | Q38289784 |
| | Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats | Q38291100 |
| | Phosphorothioate oligonucleotides bind in a non sequence-specific manner to the nucleolar protein C23/nucleolin | Q38294320 |
| | G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception | Q38307354 |
| | Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor | Q38309388 |
| | Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins | Q38321929 |
| | Different beta-subunits determine G-protein interaction with transmembrane receptors | Q38327313 |
| | Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides. | Q38339775 |
| | CREB (cAMP Response Element-Binding Protein) in the Locus Coeruleus: Biochemical, Physiological, and Behavioral Evidence for a Role in Opiate Dependence | Q38342703 |
| | Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide. | Q38350445 |
| | Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology | Q40377592 |
| | Antisense oligonucleotides as therapeutic agents--is the bullet really magical? | Q40834751 |
| | Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera | Q44555204 |
| | Suppression of NMDA Receptor Function Using Antisense DNA Blocks Ocular Dominance Plasticity While Preserving Visual Responses | Q45113813 |
| | Gene inhibition using antisense oligodeoxynucleotides | Q46429559 |
| | Selective up-regulation of an NMDA receptor subunit mRNA in cultured cerebellar granule cells by K(+)-induced depolarization and NMDA treatment | Q48196088 |
| | Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions | Q48283998 |
| | Effect of infusion of vasoactive intestinal peptide (VIP)-antisense oligodeoxynucleotide into the third cerebral ventricle above the hypothalamic suprachiasmatic nucleus on the hyperglycemia caused by intracranial injection of 2-deoxy-D-glucose in r | Q48319767 |
| | GABABR1a/R1b‐Type Receptor Antisense Deoxynucleotide Treatment of Melanotropes Blocks Chronic GABAB Receptor Inhibition of High Voltage‐Activated Ca2+ Channels | Q48403749 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurotransmitter | Q162657 |
| P304 | page(s) | 90-103 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Methods in Enzymology | Q2076903 |
| P1476 | title | Reduction of neurotransmitter receptor and G-protein expression in vivo and in vitro by antisense oligodeoxynucleotide treatment | |
| P478 | volume | 314 | |